ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets stubborn leukemia cells in rare ALL subtype
Disease control Not yet recruitingThis study tests a new drug called BEBT-908 combined with chemotherapy in adults with a rare form of acute lymphoblastic leukemia (ALL) that has a specific gene change (MEF2D). Participants are in remission but still have tiny amounts of cancer cells detectable (MRD positive). Th…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 17, 2026 00:29 UTC
-
New hope for kids with resistant leukemia: targeted drug combo enters trial
Disease control Not yet recruitingThis study tests a new drug, asciminib, given with chemotherapy and then with another drug called blinatumomab, in children, teens, and young adults up to age 30 who have a type of leukemia (Ph+ or Ph-like ALL) that has come back or not responded to treatment. The goal is to find…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug combo aims to stop leukemia relapse after transplant
Disease control Not yet recruitingThis study tests whether adding two drugs (SHR2554 and azacitidine) to standard chemotherapy before a stem cell transplant can lower the chance of leukemia returning. It includes 160 people aged 15-60 with high-risk or hard-to-treat acute leukemia or myelodysplastic syndrome. Par…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for kids with tough blood cancers: drug combo trial launches
Disease control Not yet recruitingThis study tests a combination of three drugs (capivasertib, venetoclax, and dexamethasone) in children and young adults up to age 21 whose leukemia or lymphoma has returned or not responded to treatment. The goal is to find the safest dose and see if the drugs can shrink tumors …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New shot aims to stamp out hidden leukemia cells
Disease control Not yet recruitingThis study tests whether a drug called blinatumomab, given as a shot under the skin, can control small amounts of leftover leukemia (called measurable residual disease) in adults with B-cell acute lymphoblastic leukemia. The goal is to prevent the cancer from returning. About 40 …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New immunotherapy combo aims to boost leukemia survival in adults
Disease control Not yet recruitingThis study tests a new treatment protocol for adults up to age 65 with a type of leukemia called Ph-negative ALL. The goal is to see if adding an immunotherapy drug called blinatumomab and adjusting chemotherapy can improve survival compared to an older treatment plan. About 330 …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Promising new combo therapy aims to boost survival in young leukemia patients
Disease control Not yet recruitingThis study tests a chemotherapy regimen that includes the immunotherapy drug blinatumomab for adolescents and young adults (ages 15-39) with newly diagnosed Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). The goal is to see if this treatment plan helps more p…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
Antibiotic shield: new trial aims to keep kids with leukemia Fever-Free during chemo
Disease control Not yet recruitingThis study tests whether giving the antibiotic levofloxacin to children with acute lymphoblastic leukemia (ALL) can delay or prevent the first episode of febrile neutropenia (fever with low white blood cells) during the first month of chemotherapy. About 124 children aged 1 to 18…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE4 • Sponsor: Gadjah Mada University • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
New hope for heart health in cancer survivors: drug and exercise combo trial
Disease control Not yet recruitingThis study is testing a combined program to help adult survivors of childhood leukemia who are living with obesity. Participants will receive a weekly weight-loss medication (Tirzepatide) and do supervised resistance exercises from home three times a week for 28 weeks. The main g…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 13, 2026 20:16 UTC
-
Texts to tackle chemo: study tests simple reminders for leukemia patients
Symptom relief Not yet recruitingThis study looks at whether text message reminders can help adolescents and young adults (ages 15-39) with acute lymphoblastic leukemia (ALL) stick to their daily oral chemotherapy schedule during the maintenance phase. About 38 participants will either receive frequent text remi…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 12, 2026 13:42 UTC
-
New study aims to improve Long-Term health tracking for childhood cancer survivors
Knowledge-focused Not yet recruitingThis study will follow 400 children and teens who have survived blood cancers like leukemia and lymphoma. Researchers want to understand the long-term health problems these survivors face and create a structured follow-up plan using an electronic platform. The goal is to improve …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated May 17, 2026 00:30 UTC
-
New gene test could speed up leukemia diagnosis for kids
Knowledge-focused Not yet recruitingThis study looks at whether a new genetic test called ChromoSeq® can quickly and accurately classify leukemia in children and young adults (under 30) with acute lymphoblastic leukemia (ALL). Researchers will collect bone marrow or blood samples from 60 participants at diagnosis a…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC